Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
This study has been completed.
Study NCT01388816   Information provided by Dr. Reddy's Laboratories Limited

First Received on July 5, 2011.   Last Updated on July 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type II Hyperlipidemia
Additional conditions recognized in this trial
Hyperlipidemias
Hyperlipoproteinemia Type II
More general conditions related to this trial
Dyslipidemias
Genetic Diseases, Inborn
Hyperlipoproteinemias
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Metabolic Diseases
Metabolism, Inborn Errors
Interventions listed in this trial
DRL-17822 or placebo
Sponsors listed in this trial
Dr. Reddy's Laboratories Limited
PharmaNet


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services